Inactive Instrument
Quotes Celsion Corporation Nasdaq
Stocks
US15117N4043
Biotechnology & Medical Research
|
End-of-day quote
Nasdaq
|
||
| - USD | - |
|
| 08-26 | IMUNON Hosts 2026 R&D Day Highlighting Phase 3 OVATION 3 Trial And Clinical Potential Of IMNN-001 | CI |
| 08-11 | Imunon, Inc., Q2 2026 Earnings Call, Aug 11, 2026 |
Stock exchange
Basic data
Market Cap (USD)
8,866,016
Net sales (USD)
0
Free-Float
94.86 %
Free-Float capitalization (USD)
8,410,328
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | - | 0.00% | - | - | 8.87M | |
| -0.38% | -2.64% | +42.69% | +99.03% | 67.98B | |
| -2.71% | -0.71% | +34.08% | +81.43% | 64.94B | |
| -0.31% | +6.54% | -12.96% | +377.83% | 27.58B | |
| +0.86% | +1.65% | -7.74% | -13.58% | 26.06B | |
| -1.42% | -4.28% | +31.24% | +13.27% | 25.74B | |
| -1.11% | +0.90% | +23.12% | -18.50% | 20.09B | |
| +1.15% | -14.24% | +219.82% | +381.14% | 17.16B | |
| +0.20% | -4.68% | -6.41% | +560.92% | 14.92B | |
| -0.20% | +8.37% | +55.78% | +165.57% | 14.62B | |
| Average | -0.43% | +1.05% | +42.18% | +183.01% | 27.91B | |
| Weighted average by Cap. | -0.81% | +0.59% | +36.97% | +141.12% |
Historical Quotes: Celsion Corporation
| Date | Opening | High | Low | Close | Volume | Change |
|---|
Price Extremes
- Stock Market
- Stocks
- IMNN Stock
- Stock
- Quotes Celsion Corporation
Select your edition
All financial news and data tailored to specific country editions
